株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の感染症診断薬市場予測 (2017〜2027年):疾患別収益見通し (HIV/AIDS、肝炎、結核、マラリア、クラミジア) 、技術別、エンドユーザー別、地域別収益見通し

Global Infectious Disease Diagnostics Market Forecast 2017-2027: Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique, End User and Geography

発行 Visiongain Ltd 商品コード 577297
出版日 ページ情報 英文 142 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=155.63円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
世界の感染症診断薬市場予測 (2017〜2027年):疾患別収益見通し (HIV/AIDS、肝炎、結核、マラリア、クラミジア) 、技術別、エンドユーザー別、地域別収益見通し Global Infectious Disease Diagnostics Market Forecast 2017-2027: Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique, End User and Geography
出版日: 2017年09月27日 ページ情報: 英文 142 Pages
概要

世界の感染症診断薬市場は2017年に130億米ドルを超える見込みです。同市場は2027年まで安定して収益を拡大させると予測されています。

当レポートでは、世界の感染症診断薬市場について調査し、今後の収益予測、技術別、エンドユーザー別動向、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 当レポートの概要

第2章 世界市場

  • 感染症の主な種類
  • HIV/AIDS
  • 肝炎
  • 結核
  • マラリア
  • クラミジア

第3章 技術別市場

  • 様々な技術のイントロダクション
  • 免疫測定
  • 分子診断
  • ポイントオブケア/迅速診断
  • 微生物学
    • 培養
    • 微生物同定
  • セグメント別市場シェア
  • 技術別予測

第4章 エンドユーザー別市場

  • エンドユーザーのイントロダクション
  • 病院
  • 臨床試験所
  • その他
  • エンドユーザー別市場シェア

第5章 地域別市場

  • 地域別市場
  • 米国
  • EU5か国
  • 日本
  • BRIC諸国

第6章 主要企業

  • イントロダクション
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomerieux
  • Bio-Rad Laboratories
  • Alere, Inc
  • Siemens Healthcare
  • Roche Diagnostics
  • Danaher Corporation
  • Thermo-Fisher Scientific, Inc.
  • その他の重要企業

第7章 定性分析

  • ポーター図ファイブフォース

第8章 結論と推奨

第9章 用語

目次
Product Code: PHA0243

Title:
GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST 2017-2027
Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography.

Report Details

Infectious Disease Diagnostics - our new study reveals trends, R&D progress, and predicted revenues

Where is the Infectious Disease Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 142-page report provides 83 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Infectious Disease Diagnostics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are 3 segmentations of the infectious disease diagnostics market, with forecasts for 5 Diseases, 4 Techniques and 3 End Users, each forecasted at a global level.

Global Infectious Disease Diagnostic Market by Disease Type

  • HIV/AIDS
  • Hepatitis
  • Tuberculosis
  • Malaria
  • Chlamydia

Global Infectious Disease Diagnostic Market by Technique

  • Immunoassay
  • Molecular Diagnostics
  • POC/Rapid Diagnosis
  • Microbiology

Global Infectious Disease Diagnostic Market by End User

  • Hospitals
  • Clinical Laboratories
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 11 leading national markets:

  • US
  • Germany
  • The UK
  • Italy
  • Spain
  • France
  • Japan
  • Brazil
  • China
  • India
  • Russia

The report also includes profiles and for some of the leading companies in the Infectious Disease Diagnostics market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Infectious Disease Diagnostics will surpass $13bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Infectious Disease Diagnostics Market report helps you

In summary, our 142-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for 3 segmentations of the Infectious Disease Diagnostics market, with forecasts for 5 Disease Types, 4 Techniques and 3 End Users - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 11 key national markets - See forecasts for the infectious disease diagnostics market in the US, Brazil, Germany, France, the UK, Italy, Spain, China, India, Russia and Japan
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for 9 of the major companies involved in the Infectious Disease Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Infectious Disease Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today Global Infectious Disease Diagnostics Market Forecast 2017-2027: Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Infectious Disease Diagnostics Market Overview
  • 1.2. Global Infectious Disease Diagnostics Market Segmentation
  • 1.3. Infectious Disease Diagnostics Report Structure
  • 1.4. Why You Should Read This Report
  • 1.5. How This Report Delivers
  • 1.6. Key Questions Answered by This Analytical Report
  • 1.7. Who is This Report For?
  • 1.8. Methodology
    • 1.8.1. Primary Research
    • 1.8.2. Secondary Research
    • 1.8.3. Market Evaluation & Forecasting Methodology
  • 1.9. Frequently Asked Questions(FAQ)
  • 1.10. Associated Visiongain Reports
  • 1.11. About Visiongain

2. The Global Infectious Disease Diagnostics Market(Disease Type) 2017-2027

  • 2.1. An Introduction to Major Types of Infectious Diseases
  • 2.2. HIV/AIDS
    • 2.2.1. Antibody tests
    • 2.2.2. Combination tests(Antigen/Antibody tests)
    • 2.2.3. Nucleic Acid Tests(NATS)
  • 2.3. Hepatitis
    • 2.3.1. Enzyme test
    • 2.3.2. Viral antibodies
  • 2.4. Tuberculosis
  • 2.5. Malaria
  • 2.6. Chlamydia

3. The Global Infectious Disease Diagnostics Market(Technique) 2017-2027

  • 3.1. An introduction to various types of techniques
  • 3.2. Immunoassay
  • 3.3. Molecular Diagnostics
  • 3.4. Point of care/ rapid diagnosis
  • 3.5. Microbiology
    • 3.5.1. Culture
    • 3.5.2. Microbial identification
  • 3.6. Market Shares by Segment, 2017 and 2027
  • 3.7. World Infectious Disease Diagnostics Market: Forecast by technique 2017-2027

4. The Global Infectious Disease Diagnostics Market(End User) 2017-2027

  • 4.1. An introduction to end users
  • 4.2. Hospitals
  • 4.3. Clinical Laboratories
  • 4.4. Others
  • 4.5. Market Shares by end users, 2017-2027

5. The Global Infectious Disease Diagnostics Market(Geography) 2017-2027

  • 5.1. An Introduction to the Infectious Disease Diagnostics Market by geography
  • 5.2. United States Infectious Disease Diagnostics Market
    • 5.2.1. United States Infectious Disease Diagnostics Market: by disease type
    • 5.2.2. United States Infectious Disease Diagnostics Market: by end user
  • 5.3 EU-5 Infectious Disease Diagnostics Market
    • 5.3.1. EU-5 Infectious Disease Diagnostics Market: by disease type
    • 5.3.2. EU-5 Infectious Disease Diagnostics Market: by End User
    • 5.3.3. EU-5 Infectious Disease Diagnostics Market: by Country
      • 5.3.3.1. Germany
      • 5.3.3.2. France
      • 5.3.3.3. United Kingdom
      • 5.3.3.4. Spain
      • 5.3.3.5. Italy
  • 5.4. Japan Infectious Disease Diagnostics Market
    • 5.4.1. Japan Infectious Disease Diagnostics Market: by disease type
    • 5.4.2. Japan Infectious Disease Diagnostics Market: by End User
  • 5.5. BRIC Infectious Disease Diagnostics Market
    • 5.5.1. BRIC Infectious Disease Diagnostics Market: by disease type
    • 5.5.2. BRIC Infectious Disease Diagnostics Market: by End User
    • 5.5.3. BRIC Infectious Disease Diagnostics Market: by country
  • 5.5.3.1. Brazil
  • 5.5.3.2. India
  • 5.5.3.3. Russia
  • 5.5.3.4. China

6. Leading Companies in Infectious Disease Diagnostics Market

  • 6.1. Introduction
  • 6.2. Abbott Laboratories
    • 6.2.1.1. Business Overview
    • 6.2.1.2. Recent Financials
    • 6.2.1.3. Product Offerings
    • 6.2.1.4. Recent developments
  • 6.3. Becton, Dickinson and Company
    • 6.3.1.1. Business Overview
    • 6.3.1.2. Recent Financials
    • 6.3.1.3. Product Offerings
    • 6.3.1.4. Recent developments
  • 6.4. Biomérieux
    • 6.4.1.1. Business Overview
    • 6.4.1.2. Recent Financials
    • 6.4.1.3. Product Offerings
    • 6.4.1.4. Recent developments
  • 6.5. Bio-Rad Laboratories
    • 6.5.1.1. Business Overview
    • 6.5.1.2. Recent Financials
    • 6.5.1.3. Product Offerings
    • 6.5.1.4. Recent developments
  • 6.6. Alere, Inc
    • 6.6.1.1. Business Overview
    • 6.6.1.2. Recent Financials
    • 6.6.1.3. Product Offerings
    • 6.6.1.4. Recent developments
  • 6.7. Siemens Healthcare
    • 6.7.1.1. Business Overview
    • 6.7.1.2. Recent Financials
    • 6.7.1.3. Product Offerings
    • 6.7.1.4. Recent Developments
  • 6.8. Roche Diagnostics
    • 6.8.1.1. Business Overview
    • 6.8.1.2. Recent Financials
    • 6.8.1.3. Product Offerings
    • 6.8.1.4. Recent Developments
  • 6.9. Danaher Corporation
    • 6.9.1.1. Business Overview
    • 6.9.1.2. Recent Financials:
    • 6.9.1.3. Product and Service Offerings
    • 6.9.1.4. Recent developments
  • 6.10. Thermo-Fisher Scientific, Inc.
    • 6.10.1.1. Recent Financials
    • 6.10.1.2. Product Offerings
    • 6.10.1.3. Recent Developments
  • 6.11. Other Players of Importance within the Global Infectious Disease Diagnostics Industry

7. Qualitative Analysis

  • 7.1. Porter's Five Forces Analysis
    • 7.1.1. Bargaining Power of Buyers
    • 7.1.2. Bargaining Power of Suppliers
    • 7.1.3. Industry Rivalry
    • 7.1.4. Threat of New Entrants
    • 7.1.5. Threat of Substitutes

8. Conclusion and Recommendation

  • 8.1. Key Take-Away
  • 8.2. Conclusion

9. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain Report Evaluation Form

List of Figures

  • Figure 2.1: Prevalence of HIV/Aids In Major Countries
  • Figure 2.2: Incidence Of Hiv Across Various Countries
  • Figure 2.3: Incidence of Hepatitis Forecast(2017-2027)
  • Figure 2.4: Forecasted Cases Of Tuberculosis(2017-2027)
  • Figure 2.5: Forecasted Cases Of Malaria(2017-2027)
  • Figure 2.6: Forecasted Cases Of Chlamydia(2017-2027)
  • Figure 3.1: Percentage Contribution Of Individual Segment- 2017
  • Figure 3.2: Percentage Contribution Of Individual Segment- 2027
  • Figure 3.3: Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, 2017-2027
  • Figure 3.4: Global Immunoassay Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Figure 3.5: Global Microbiology Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Figure 3.6: Global Rapid/POC Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Figure 4.1.: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Figure 4.2: Global Infectious Disease Diagnostics end user: Clinical Laboratories Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Figure 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast,(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Figure 4.4: Infectious Disease Diagnostics End-User Market Share(%) 2017
  • Figure 4.5: Infectious Disease Diagnostics End-User Market Share(%) 2027
  • Figure 5.1. Infectious Disease Diagnostics Market, Regional Market Share, 2017(%)
  • Figure 5.2. Infectious Disease Diagnostics Market, Regional Market Share, 2027(%)
  • Figure 5.3: US Infectious Disease Diagnostics Market Forecast,(Revenue, $bn, AGR %) 2017-2027
  • Figure 5.4: US Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027
  • Figure 5.5: US Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn) 2017-2027
  • Figure 5.6: EU-5 Infectious Disease Diagnostics Market Forecast(Revenue, $bn, AGR %) 2017-2027
  • Figure 5.7. Infectious Disease Diagnostics market, Disease cases, 2017-2027, EU-5
  • Figure 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn) 2017-2027
  • Figure 5.9: EU-5 Infectious Disease Diagnostics Market Forecast, By Country(Revenue, $bn, AGR %) 2017-2027
  • Figure 5.10: Japanese Infectious Disease Diagnostics Market Forecast, By Country(Revenue, $bn, AGR %) 2017-2027
  • Figure 5.11. Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027, Japan
  • Figure 5.12: Japan Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Figure 5.13: BRIC Infectious Disease Diagnostics Market Forecast, By Market(Revenue, $bn, AGR %) 2017-2027
  • Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
  • Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn) 2017-2027
  • Figure 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country(Revenue, $bn) 2017-2027
  • Figure 7.1: Porter's Five Forces Analysis for the Infectious Disease Diagnostics Market

List of Tables

  • Table 2.1: Prevalence Forecast of HIV/AIDS in major countries(Mn, 2017-2027)
  • Table 2.2: Incidence of HIV across various countries(2017-2027)
  • Table 2.3: Incidence of Hepatitis Forecast(2017-2027)
  • Table 2.4: Forecasted Incidence Of Tuberculosis(2017-2027)
  • Table 2.5: Forecasted Incidences of Malaria(2017-2027)
  • Table 2.6: Incidences of Chlamydia(2017-2027)
  • Table 3.1: infectious disease diagnoses By Share(%, 2017)
  • Table 3.2: infectious disease diagnoses By Share(%, 2027)
  • Table 3.3: Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, and CAGR %, 2017-2027
  • Table 3.4: Global Immunoassay Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Table 3.5: Global Microbiology Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Table 3.6: Global Rapid/POC Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Table 4.1: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Table 4.2: Global Infectious Disease Diagnostics: Clinical Laboratories Market Forecast,(Revenue $bn, AGR % and CAGR %) 2017-2027
  • Table 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast,(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.1: Infectious Disease Diagnostics Market Forecast,(Geographical Distribution, $bn, AGR %) 2017-2027
  • Table 5.2: US Infectious Disease Diagnostics Market Forecast,(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.3: US Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027
  • Table 5.4: US Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.5: EU-5 Infectious Disease Diagnostics Market Forecast(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.6: EU-5 Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027
  • Table 5.7: EU-5 Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By Country(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.9: Japanese Infectious Disease Diagnostics Market Forecast,(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.10: Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027, Japan
  • Table 5.11: Japan Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.12: BRIC Infectious Disease Diagnostics Market Forecast,(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.13: BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
  • Table 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country(Revenue, $bn, AGR % and CAGR %) 2017-2027
  • Table 6.1: Abbott Laboratories- Key Facts
  • Table 6.2: Abbott Recent Financials
  • Table 6.3: Becton, Dickinson and Company- Key Facts
  • Table 6.4: Becton, Dickinson and Company Recent Financials
  • Table 6.5: bioMérieux S.A. - Key Facts
  • Table 6.6: bioMérieux S.A.Recent Financials
  • Table 6.7: Bio-Rad - Key Facts
  • Table 6.8: Bio-Rad - Recent Financials
  • Table 6.9: Alere - Key Facts
  • Table 6.10: Alere - Recent Financials
  • Table 6.11: Siemens Healthcare - Key Facts
  • Table 6.12: Siemens Healthcare - Recent Financials
  • Table 6.13: Roche Diagnostics - Key Facts
  • Table 6.14: Danaher Corporation- Key Facts
  • Table 6.15: Danaher Corporation.- Recent Financials
  • Table 6.16: Thermo Fisher Scientific Inc.- Key Facts
  • Table 6.17: Thermo Fisher Scientific Inc.- Recent Financials
  • Table 6.18: Companies of interest in the Infectious Disease Diagnostics Market

Companies Listed:

  • 3M
  • Abaxis
  • Abaxis Inc
  • Abbott Laboratories
  • Advanced Care
  • Affymetrix, Inc.
  • AgaMatrix
  • Agendia BV
  • Alere Health Systems Inc.
  • Amgenix International Inc
  • Arkay
  • Ascensia Diabetes Care
  • Astra Zeneca
  • AutoGenomics, Inc.
  • Avioq, Inc.
  • B Braun
  • Bayer
  • BBI Helathcare
  • Becton Dickinson
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
  • Biofire Diagnostics
  • BioLytical Laboratories
  • Bionime
  • Bio-Rad Laboratories
  • Biosense Medical
  • BioSign
  • Biosite Diagnostics
  • Biosynex Medtech
  • Boehringer Ingelheim
  • Calypte Biomedical
  • Celera Diagnostics
  • Cepheid
  • Cerus Corporation
  • Chembio Diagnostic Systems
  • Cholestech
  • Church & Dwight
  • Clinical Micro Sensors, Inc.
  • Concateno
  • Core Diagnostics
  • CVS/Pharmacy
  • Dako Denmark A/S
  • DakoCytomation Denmark A/S
  • Dario Health
  • Decision Diagnostics Corp.
  • Dexcom
  • Diabetic Supply of Suncoast
  • Diagnostic Devices
  • DiME
  • Early Pregnancy Tests.com
  • EKF Diagnostics
  • Entra Helath Systems
  • Exact Sciences Corporation
  • EY Laboratories
  • Fenwal Inc
  • Fifty50 Medical
  • Focus Diagnostics
  • ForaCare
  • Fujirebio
  • Genentech
  • General Life Biotechnology Ltd
  • Genesis Health Technology
  • GenMark Diagnostics
  • Gen-Probe, Inc.
  • Genzyme
  • Gluco Com
  • Grove Instruments
  • Halifax
  • Helena Laboratories
  • Hema technologies
  • Hologic, Inc.
  • Home Access Health Corporation
  • Horiba
  • IHelath Labs
  • Illumina, Inc.
  • IME-DC
  • IND Diagnostic Inc.
  • Infopia
  • Insight Pharmaceuticals
  • Instrumentation Laboratory(a company of Werfen Group)
  • InTec Products
  • Integrity Applications Ltd.
  • International Technidyne Corporation
  • Inverness Medical
  • Iris Molecular Diagnostics
  • JANT Pharmacal Corporation
  • Johnson & Johnson
  • LifeScan
  • Livongo Health
  • Luminex Molecular Diagnostics, Inc.
  • Marnes La Coquette
  • Maxim Biomedical Inc
  • Medford
  • Medix Biochemica
  • Medor
  • Menarini
  • Meridian Bioscience
  • Mitsubishi Chemical
  • MIZUHO MEDY Company
  • Myriad Genetic Laboratories, Inc.
  • Nani Daman
  • Nanosphere, Inc.
  • Nanostring Technologies
  • Nipro Diadnostics
  • Nova Diabetes
  • Oak Tree Health
  • Oak Tree International Holdings
  • Omnis Health
  • One Drop
  • OraSure Technologies
  • Orgenics
  • OrSense NBM-200G
  • Ortho-Clinical Diagnostics, Inc.
  • Osmetech Molecular Diagnostics
  • ParagonDx, LLC
  • Partec
  • Pathwork Diagnostics Inc.
  • Pharma Tech Solutions
  • Philosys
  • POC Medical System
  • PointCare Technologies
  • Polymer Technology Systems Inc
  • Premier Medical Corporation
  • Princeton Biomedtech
  • Procter & Gamble
  • Prodigy Diabetes Care
  • Proteome Systems
  • Quest Diagnostics
  • Quidel
  • Remel/Thermofisher
  • Response Biomedical Corporation
  • Roche Diagnostics Corporation
  • Roche Molecular Systems, Inc.
  • RunBio Biotech Company
  • SA Scientific
  • Sanofi
  • Siemens Healthcare Diagnostics GmbH
  • Spartan Bioscience, Inc.
  • Spirit Healthcare
  • Standard Diagnostics Inc.
  • Swiss Precision Diagnostics
  • Symphony
  • Sysmex
  • Telcare
  • Thermo Fisher Scientific
  • Third Wave Technologies Inc.
  • Tm Bioscience Corporation
  • TrimGen Corporation
  • Trinity Biotech
  • Trividia Health
  • Trovagene
  • U.S. Diagnostics
  • Unimed International
  • Universal Biosensors
  • Universal Diagnostics
  • Ventana Medical Systems, Inc.
  • Veridex, LLC.
  • Vysis
  • WellDoc Corporation
  • xDx Inc.
  • YD Diagnostics

List of Organizations:

  • Australian Institute Of Health And Welfare
  • European Medicines Agency
  • Food Drug and Administration
  • Health Canada
  • Ministry of Health, Labor and Welfare
  • National Cancer Institute
  • The American Society Of Clinical Oncology Inc
  • The Feinstein Institute For Medical Research
  • United States Department Of Health & Human Services
  • World Health Organization
Back to Top